Carregant...
Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy
The clinical heterogeneity of the myelodysplastic syndromes (MDSs) relates to the recently discerned panoply of molecular abnormalities extant within this disease spectrum. Despite increasing recognition of these biologic abnormalities, very limited therapeutic options exist to exploit our increasin...
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199665/ https://ncbi.nlm.nih.gov/pubmed/30352953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018015834 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|